Salivary gland and autoimmunity

Journal of Medical Investigation

Volumn 56, Issue SUPPL. 1, 2009, Pages 185-191

  Hayashi, Yoshio ^a   Arakaki, Rieko ^a   Ishimaru, Naozumi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Autoimmunity; RbAp48; Salivary gland; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; CLASS 2 TRANSACTIVATOR PROTEIN; ESTROGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 18 BINDING PROTEIN; RETINOBLASTOMA BINDING PROTEIN 4; RETINOBLASTOMA PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE EXOCRINOPATHY; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EPITHELIUM CELL; ESTROGEN DEFICIENCY; IMMUNOCOMPETENT CELL; LYMPH NODE CELL; MOUSE; NONHUMAN; SALIVARY GLAND DISEASE; SEX DIFFERENCE; SHORT SURVEY; SJOEGREN SYNDROME; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; RETINOBLASTOMA-BINDING PROTEIN 4; SALIVARY GLANDS; SEX CHARACTERISTICS; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

MUS;

EID: 77749302380     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.56.185     Document Type: Short Survey

References (46)

1. Fox RI, Stern M, Michelson P : Update in Sjögren's syndrome. Curr Opin Rheumatol 12 : 391-398, 2000
2. Manoussakis MN, Moutsopoulos HM : Sjögren's syndrome : current concepts. Adv Intern Med 47 : 191-217, 2001
3. Chan EK, Hamel JC, Buyon JP, Tan EM : Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 87 : 68-76, 1991
4. Kruize AA, Smeenk RJT, Kater L : Diagnostic criteria and immunopathogenesis of Sjögren's syndrome : implications for therapy. Immunol Today 16 : 557-559, 1995
5. Li H, Dai M, Zhuang Y : A T cell intrinsic role of Id3 in a mouse model for primary Sjögren's syndrome. Immunity 21 : 551-560, 2004
6. Patel YI, McHugh NJ : Apoptosis-new clues to the pathogenesis of Sjögren's syndrome?, Rheumatology (Oxford) 39 : 119-121, 2000
7. Masaki Y, Sugai S : Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 3 : 175-182, 2004
8. Lavie F, Miceil-Richard C, Quillard J, Roux S, Leclerc P, Mariette X : Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. J Pathol 202 : 496-502, 2004
9. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F : Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 109 : 59-68, 2002.
10. Thompson CB : Apoptosis in the pathogenesis and treatment of disease. Science 267 : 1456-1462, 1995
11. Bieganowska KD, Ausubel LJ, Modabber Y, Slovik E, Messersmith W, Hafler DA : Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. J Exp Med 185 : 1585-1594, 1997
12. Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, Ulevitch RJ, Nemerow GR, Han J : Apoptosis signaling pathway in T cells is composed of ICE/Ced- 3 familiy proteases and MAP kinase kinase 6b. Immunity 6 : 739-749, 1997
13. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT : Caspase-3-generated fragment of Gelsolin : Effector of morphological change in apoptosis. Science 278 : 294-298, 1997
14. Brunner, T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Daouglas RG : Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373 : 441-444, 1995
15. Ju S-T, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A : Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373 : 444-448, 1995
16. Ito M, Terasaki S, Itoh J, Katoh H, Yonehara S, Nose M : Rheumatic Disease in an MRL strain of mice with a deficit in functional Fas ligand. Arthritis Rheum 40 : 1054-1063, 1997
17. Ludgate M, Jasani B : Apoptosis in autoimmune and non-autoimmune thyroid desease. J Pathol 182 : 123-124, 1997
18. Casiano CA : Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1) -mediated T cell apoptosis. J Exp Med 184 : 765-770, 1996
19. Rieux-Laucat F : Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 : 1347-1349, 1995
20. Casciola-Rosen L, Rosen A, Petri M, Schlissel M : Surface blebs on apoptotic cells are sites of enchanced procoagulant activity implications for coaglation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 93 : 1624-1629, 1996
21. Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS : Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 157 : 2201-2208, 1996
22. Miranda-Carus ME, Askanase AD, Clancy RM, Di Donato F, Chou TM, Libera MR, Chan EK, Buyon JP : Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages. J Immunol 165 : 5345-5351, 2000
23. Augstein P, Elefanty AG, Allison J, Harrison LC : Apoptosis and β-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41 : 1381-1388, 1998
24. Mandrup-Poulsen T : β-Cell apoptosis : stimuli and signaling. Diabetes 50 : S58-S63, 2001
25. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y : Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 276 : 604-607, 1997
26. Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y : Analysis of in vivo role of α-fodrin autoantigen in primary Sjögren's syndrome. Am J Pathol 167 : 1051-1059, 2005.
27. Utz PJ, Hottelet M, Schur PH, Anderson P : Proteins phospholylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 185 : 843-854, 1997
28. Humpherys-Beher MG, Peck AB, Dang H, Talal N : The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome. Clin Exp Immunol 116 : 383-387, 1999
29. Ishimaru N, Yanagi K, Ogawa K, Suda T, Saito I, Hayashi Y : Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome. J Immunol 167 : 6031-6037, 2001
30. Saegusa K, Yanagi K, Ogawa K, Suda I, Saito I, Hayashi Y : Prevention and induction of auto-immune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome. J Immunol 169 : 1050-1057, 2002
31. Parijs LV, Abbas AK : Homeostasis and self-tolerance in the immune system : Turning lymphocytes off. Science 280 : 243-248, 1998
32. Ishimaru N, Arakaki R, Omotehara F, Yamada K, Mishima K, Saito I, Hayashi Y : Novel role of RbAp48 for tissue-specific estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 26 : 2924-2935, 2006
33. Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y : Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy. J Exp Med 205 : 2915 -2927, 2008
34. Berland R, Wortis HH : Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20 : 253-300, 2002
35. Londei M, Lamb JR, Bottazzo GF, Feldmann M : Epithelial cell expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312 : 639-641, 1984
36. He XL, Radu C, Sidney J, Sette A, Ward ES, Garcia KC : Structural snapshot of aberrant antigen presentation linked to autoimmunity : the immunodominant epitope of MBP complexed with I-Au. Immunity 17 : 83-94, 2002
37. Germain RN : MHC-dependent antigen processing and peptide presentation : providing ligands for T lymphocyte activation. Cell 76 : 287-299, 1994
38. Giroux M, Schmidt M, Descoteaux A : IFN-γ-induced MHC class II expression : transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-α. J Immunol 171 : 4187-4194, 2002
39. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF : IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 158 : 4260-4269, 1997
40. Ting JP, Trowsdale J : Genetic control of MHC class II expression. Cell 109 : S21-33, 2002
41. Wright KL, Ting JP : Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol 27 : 405-412, 2006
42. Elser B, Lohoff M, Kock S, Giaisi M, Kirchhoff S, Krammer PH, Li-Weber M : IFN-γ represses IL-4 expression via IRF-1 and IRF-2. Immunity 17 : 703-712, 2002
43. Shirasuna K, Sato M, Miyazaki T : A neoplastic epithelial duct cell line established form an irradiated human salivary gland. Cancer 48 : 745-752, 1981
44. Howard AY : Unravelling the Pros and Cons of interferon-γ gene regulation. Immunity 24 : 506-507, 2006
45. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H : Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 : 423-474, 2001
46. Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C : Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome : relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 6 : 447-456, 2004